Introduction: 68Ga-PSMA-PET/CT has proven its value in prostate cancer with high positive predictive value for lymph node metastasis and superior detection of distant metastasis. There is growing evidence that 68Ga-PSMA- PET/CT has high sensitivity for detection of tumor lesions in the prostate as well. Studies thus far have mainly been performed in patients prior to prostatectomy. Aim of this study is to evaluate diagnostic accuracy in a mixed population of men with increased risk of prostate cancer and evaluate diagnostic possibilities with respect to extra-capsular extension and seminal vesicle invasion. Methods: The population consisted of a retrospectively included sequential cohort of 69 patients with 68Ga-PSMA-PET/CT and mpMRI available. 68Ga-PSMA-PET/CT was re-evaluated by two readers blinded for mpMRI and clinical information. Likelihood of tumour presence, extra-prostatic extension and seminal vesicle invasion was scored on 5-point Likert scale and localized schematically. Results were compared with mpMRI. Available pathological outcome served as gold standard. SUVmax of index lesions was measured and correlated to index tumor Gleason grade. Results: Clinically significant prostate cancer (Gleason ≥ 3 + 4) was detected in 57 (83%) of 69 patients. Diagnostic accuracy was 89% for PET reader 1, 93% for PET reader 2 and 86% for mpMRI. Lesion concordance of 68Ga-PSMA-PET/CT and mpMRI was 97%. SUVmax of the index lesion correlated to Gleason grade. Sensitivity for extracapsular extension in the prostatectomy group was 62% for PET reader 1, 33% for PET reader 2 and 50% for mpMRI. Specificity was 62% for PET reader 1, 100% for PET reader 2 and 69% for mpMRI. Conclusion: Ga68-PSMA-PET shows high accuracy in the detection of tumor lesions in the prostate. Results on evaluating extra-capsular extension and seminal vesicle invasion are comparable to mpMRI. This study adds to the increasing evidence that 68Ga-PSMA-PET/CT is imperative in detection of prostate cancer prior to biopsy.
References
[1]
Ahmed, H.U., El-ShaterBosaily, A., Brown, L.C., Gabe, R., Kaplan, R., Parmar, M.K., et al. (2017) Diagnostic Accuracy of Multi-Parametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study. The Lancet, 389, 815-822. https://doi.org/10.1016/S0140-6736(16)32401-1
[2]
Kasivisvanathan, V., Rannikko, A.S., Borghi, M., Panebianco, V., Mynderse, L.A., Vaarala, M.H., et al. (2018) MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. The New England Journal of Medicine, 19, 1767-1777. https://doi.org/10.1056/NEJMoa1801993
[3]
Dell’Oglio, P., Stabile, A., Soligo, M., Brembilla, G., Esposito, A., Gandaglia, G., et al. (2020) There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies. European Urology Oncology, 1, 112-118. https://doi.org/10.1016/j.euo.2019.03.002
[4]
Kohestani, K., Wallstrom, J., Dehlfors, N., Sponga, O.M., Mansson, M., Josefsson, A., et al. (2019) Performance and Inter-Observer Variability of Prostate MRI (PI- RADS Version 2) outside High-Volume Centres. Scandinavian Journal of Urology, 5, 304-311. https://doi.org/10.1080/21681805.2019.1675757
[5]
Dianat, S.S., Carter, H.B. and Macura, K.J. (2014) Performance of Multiparametric Magnetic Resonance Imaging in the Evaluation and Management of Clinically Low- Risk Prostate Cancer. Urologic Oncology, 1, 39.e1-10. https://doi.org/10.1016/j.urolonc.2013.04.002
[6]
Schouten, M.G., van der Leest, M., Pokorny, M., Hoogenboom, M., Barentsz, J.O., Thompson, L.C. and Fütterer, J.J. (2016) Why and Where Do We Miss Significant Prostate Cancer with Multi-Parametric Magnetic Resonance Imaging Followed by Magnetic Resonance-Guided and Transrectal Ultrasound-Guided Biopsy in Biopsy-Naïve Men? European Urology, 6, 896-903. https://doi.org/10.1016/j.eururo.2016.12.006
[7]
Woo, S., Suh, C.H., Kim, S.Y., Cho, J.Y. and Kim, S.H. (2017) Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis. European Urology, 2, 177-188. https://doi.org/10.1016/j.eururo.2017.01.042
[8]
Purysko, A.S., Bittencourt, L.K., Bullen, J.A., Mostardeiro, T.R., Herts, B.R. and Klein, E.A. (2017) Accuracy and Interobserver Agreement for Prostate Imaging Reporting and Data System, Version 2, for the Characterization of Lesions Identified on Multiparametric MRI of the Prostate. American Journal of Roentgenology, 2, 339-349. https://doi.org/10.2214/AJR.16.17289
[9]
Eissa, A., Elsherbiny, A., Coelho, R.F., Rassweiler, J., Davis, J.W., Porpiglia, F., et al. (2018) The Role of 68Ga-PSMA PET/CT Scan in Biochemical Recurrence after Primary Treatment for Prostate Cancer: A Systematic Review of the Literature. Minerva Urologica e Nefrologica, 5, 462-478. https://doi.org/10.23736/S0393-2249.18.03081-3
[10]
Corfield, J., Perera, M., Bolton, D. and Lawrentschuk, N. (2018) (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) for Primary Staging of High-Risk Prostate Cancer: A Systematic Review. World Journal of Urology, 4, 519-527. https://doi.org/10.1007/s00345-018-2182-1
[11]
Kopp, J., Kopp, D., Bernhardt, E., Manka, L., Beck, A., Gerullis, H., et al. (2020) (68)Ga-PSMA PET/CT Based Primary Staging and Histological Correlation after Extended Pelvic Lymph Node Dissection at Radical Prostatectomy. World Journal of Urology. https://doi.org/10.1007/s00345-020-03131-0
[12]
Luiting, H.B., van Leeuwen, P.J., Busstra, M.B., Brabander, T., van der Poel, H.G., Donswijk, M.L., et al. (2020) Use of Gallium-68 Prostate-Specific Membrane Antigen Positron-Emission Tomography for Detecting Lymph Node Metastases in Primary and Recurrent Prostate Cancer and Location of Recurrence after Radical Prostatectomy: An Overview of the Current Literature. BJU International, 2, 206-214. https://doi.org/10.1111/bju.14944
[13]
Maurer, T., Gschwend, J.E., Rauscher, I., Souvatzoglou, M., Haller, B., Weirich, G., et al. (2016) Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer. The Journal of Urology, 5, 1436-1443. https://doi.org/10.1016/j.juro.2015.12.025
[14]
Donato, P., Morton, A., Yaxley, J., Ranasinghe, S., Teloken, P.E., Kyle, S., et al. (2020) (68)Ga-PSMA PET/CT Better Characteriseslocalised Prostate Cancer after MRI and Transperineal Prostate Biopsy: Is (68)Ga-PSMA PET/CT Guided Biopsy the Future? European Journal of Nuclear Medicine and Molecular Imaging, 8, 1843- 1851. https://doi.org/10.1007/s00259-019-04620-0
[15]
Spohn, S., Jaegle, C., Fassbender, T.F., Sprave, T., Gkika, E., Nicolay, N.H., et al. (2020) Intraindividual Comparison between (68)Ga-PSMA-PET/CT and mpMRI for Intraprostatic Tumor Delineation in Patients with Primary Prostate Cancer: A Retrospective Analysis in 101 Patients. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-020-04827-6
[16]
Scheltema, M.J., Chang, J.I., Stricker, P.D., van Leeuwen, P.J., Nguyen, Q.A., Ho, B., et al. (2019) Diagnostic Accuracy of (68)Ga-Prostate-Specific Membrane Antigen (PSMA) Positron-Emission Tomography (PET) and Multiparametric (mp) MRI to Detect Intermediate-Grade Intra-Prostatic Prostate Cancer Using Whole-Mount Pathology: Impact of the Addition of (68)Ga-PSMA PET to mpMRI. BJU International, 124, 42-49. https://doi.org/10.1111/bju.14794
[17]
Donato, P., Roberts, M.J., Morton, A., Kyle, S., Coughlin, G., Esler, R., et al. (2019) Improved Specificity with (68)Ga PSMA PET/CT to Detect Clinically Significant Lesions “Invisible” on Multiparametric MRI of the Prostate: A Single Institution Comparative Analysis with Radical Prostatectomy Histology. European Journal of Nuclear Medicine and Molecular Imaging, 1, 20-30. https://doi.org/10.1007/s00259-018-4160-7
[18]
Kalapara, A.A., Nzenza, T., Pan, H.Y., Ballok, Z., Ramdave, S., O’Sullivan, R., et al. (2019) Detection and Localisation of Primary Prostate Cancer Using (68)Ga-PSMA PET/CT Compared with mpMRI and Radical Prostatectomy Specimens. BJU International. https://doi.org/10.1111/bju.14858
[19]
Bettermann, A.S., Zamboglou, C., Kiefer, S., Jilg, C.A., Spohn, S., Kranz-Rudolph, J., et al. (2019) (68)Ga-PSMA-11 PET/CT and Multiparametric MRI for Gross Tumor Volume Delineation in a Slice by Slice Analysis with Whole Mount Histopathology as a Reference Standard Implications for Focal Radiotherapy Planning in Primary Prostate Cancer. Radiotherapy and Oncology, 141, 214-219. https://doi.org/10.1016/j.radonc.2019.07.005
[20]
Lopci, E., Saita, A., Lazzeri, M., Lughezzani, G., Colombo, P., Buffi, N.M., et al. (2018) (68)Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study. Journal of Urology, 1, 95-103. https://doi.org/10.1016/j.juro.2018.01.079
[21]
Hofman, M.S., Murphy, D.G., Williams, S.G., Nzenza, T., Herschtal, A., Lourenco, R.A., et al. (2018) A Prospective Randomized Multicentre Study of the Impact of Gallium-68 Prostate-Specific Membrane Antigen (PSMA) PET/CT Imaging for Staging High-Risk Prostate Cancer Prior to Curative-Intent Surgery or Radiotherapy (proPSMA Study): Clinical Trial Protocol. BJU International, 5, 783-793. https://doi.org/10.1111/bju.14374
[22]
Uprimny, C., Kroiss, A.S., Decristoforo, C., Fritz, J., von Guggenberg, E., Kendler, D., et al. (2017) (68)Ga-PSMA-11 PET/CT in Primary Staging of Prostate Cancer: PSA and Gleason Score Predict the Intensity of Tracer Accumulation in the Primary Tumour. European Journal of Nuclear Medicine and Molecular Imaging, 6, 941- 949. https://doi.org/10.1007/s00259-017-3631-6
[23]
Turkbey, B., Mena, E., Lindenberg, L., Adler, S., Bednarova, S., Berman, R., et al. (2017) 18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation with Multiparametric MRI and Histopathology. Clinical Nuclear Medicine, 10, 735-740. https://doi.org/10.1097/RLU.0000000000001804
[24]
Kesch, C., Vinsensia, M., Radtke, J.P., Schlemmer, H.P., Heller, M., Ellert, E., et al. (2017) Intraindividual Comparison of ^sup 18^F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study. The Journal of Nuclear Medicine, 11, 1805. https://doi.org/10.2967/jnumed.116.189233
[25]
von Klot, C.J., Merseburger, A.S., Boker, A., Schmuck, S., Ross, T.L., Bengel, F.M., et al. (2017) (68)Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer. Nuclear Medicine and Molecular Imaging, 4, 314-322. https://doi.org/10.1007/s13139-017-0476-7
[26]
Muehlematter, U.J., Burger, I.A., Becker, A.S., Schawkat, K., Hotker, A.M., Reiner, C.S., et al. (2019) Diagnostic Accuracy of Multiparametric MRI versus (68)Ga- PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer. Radiology, 2, 350-358. https://doi.org/10.1148/radiol.2019190687
[27]
Declaration of Helsinki. https://www.wma.net
[28]
Medical Research Involving Human Subjects Act. https://english.ccmo.nl/investigators/legal-framework-for-medical-scientific-research/laws/medical-research-involving-human-subjects-act-wmo
[29]
Epstein, J.I., Allsbrook, W.C., Amin, M.B., Egevad, L.L. and ISUP Grading Committee (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. The American Journal of Surgical Pathology, 9, 1228-1242. https://doi.org/10.1097/01.pas.0000173646.99337.b1
[30]
Lopci, E., Lughezzani, G., Castello, A., Saita, A., Colombo, P., Hurle, R., et al. (2020) Prospective Evaluation of (68)Ga-Labeled Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer Diagnosis. European Urology Focus. https://doi.org/10.1016/j.euf.2020.03.004
[31]
Zamboglou, C., Drendel, V., Jilg, C.A., Rischke, H.C., Beck, T.I., Schultze-Seemann, W., et al. (2017) Comparison of (68)Ga-HBED-CC PSMA-PET/CT and Multiparametric MRI for Gross Tumour Volume Detection in Patients with Primary Prostate Cancer Based on Slice by Slice Comparison with Histopathology. Theranostics, 1, 228-237. https://doi.org/10.7150/thno.16638
[32]
Budaus, L., Leyh-Bannurah, S.R., Salomon, G., Michl, U., Heinzer, H., Huland, H., et al. (2016) Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-Risk Prostate Cancer Patients Prior to Radical Prostatectomy. European Urology, 3, 393- 396. https://doi.org/10.1016/j.eururo.2015.06.010
[33]
de Rooij, M., Hamoen, E.J.H., Witjes, J.A., Barentsz, J.O. and Rovers, M.M. (2015) Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-Analysis. European Urology, 2, 233-245. https://doi.org/10.1016/j.eururo.2015.07.029
[34]
Chen, M., Zhang, Q., Zhang, C., Zhou, Y.H., Zhao, X., Fu, Y., et al. (2020) Comparison of (68)Ga-Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) and Multi-Parametric Magnetic Resonance Imaging (MRI) in the Evaluation of Tumor Extension of Primary Prostate Cancer. Translational Andrology and Urology, 2, 382-390. https://doi.org/10.21037/tau.2020.03.06
[35]
Fei, B., Schuster, D.M., Master, V., Akbari, H., Fenster, A. and Nieh, P. (2012) A Molecular Image-Directed, 3D Ultrasound-Guided Biopsy System for the Prostate. Proceedings of SPIE—The International Society for Optical Engineering, Volume 8316, Article ID: 831613. https://doi.org/10.1117/12.912182
[36]
Lazzeri, M., Lopci, E., Lughezzani, G., Colombo, P., Casale, P., Hurle, R., et al. (2017) Targeted 11C-Choline PET-CT/TRUS Software Fusion-Guided Prostate Biopsy in Men with Persistently Elevated PSA and Negative mpMRI after Previous Negative Biopsy. European Journal of Hybrid Imaging, 1, 9. https://doi.org/10.1186/s41824-017-0011-1
[37]
Zettinig, O., Shah, A., Hennersperger, C., Eiber, M., Kroll, C., Kubler, H., et al. (2015) Multimodal Image-Guided Prostate Fusion Biopsy Based on Automatic Deformable Registration. International Journal of Computer Assisted Radiology and Surgery, 12, 1997-2007. https://doi.org/10.1007/s11548-015-1233-y
